Prokidney (PROK) Retained Earnings (2021 - 2026)
Prokidney's (PROK) quarterly Retained Earnings came in at -$1.3 billion in Q1 2026, down 689.18% year-on-year from $218.9 million in Q1 2025, and down 2303442.86% on a QoQ basis from $56000.0 in Q4 2025.
Prokidney (PROK) Retained Earnings (2021 - 2026) Analysis & Trends
Prokidney (PROK) has 6 years of Retained Earnings data on file, last reported at -$1.3 billion in Q1 2026.
- On a quarterly basis, Retained Earnings fell 689.18% year-over-year to -$1.3 billion in Q1 2026; TTM through Mar 2026 was -$1.3 billion, a 689.18% decrease from a year earlier, with the FY2025 full-year figure at $56000.0, down 56.92% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.3 billion, down from $56000.0 in the prior quarter.
- Over the last five years, Retained Earnings for PROK reached as high as $242.5 million in Q3 2025 and fell as low as -$1.3 billion in Q1 2026.
- Historically, Retained Earnings has averaged -$395.6 million across 5 years, with a median of -$6.2 million in 2022.
- Across the five-year window, Retained Earnings surged 276.3% in 2023 and sank 1842979.69% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$1.1 billion in 2022, then decreased by 3.81% to -$1.1 billion in 2023, then surged by 100.01% to $130000.0 in 2024, then sank by 56.92% to $56000.0 in 2025, then tumbled by 2303442.86% to -$1.3 billion in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$1.3 billion in Q1 2026, $56000.0 in Q4 2025, and $242.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Prokidney | 96.00 Mn | 96.00 Mn | - | -1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Bn |
| Dec 31, 2025 | 56,000.00 |
| Sep 30, 2025 | 242.48 Mn |
| Jun 30, 2025 | 231.58 Mn |
| Mar 31, 2025 | 218.93 Mn |
| Dec 31, 2024 | 130,000.00 |
| Sep 30, 2024 | -1.18 Bn |
| Jun 30, 2024 | -1.16 Bn |
| Mar 31, 2024 | -1.15 Bn |
| Dec 31, 2023 | -1.14 Bn |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | -127,000.00 |
| Mar 31, 2023 | 21.79 Mn |
| Sep 30, 2022 | -1.10 Bn |
| Jun 30, 2022 | -15.00 Mn |
| Mar 31, 2022 | -12.36 Mn |
| Sep 30, 2021 | -6.32 Mn |
| Jun 30, 2021 | -5,325.00 |